Novo Nordisk launches weight-loss drug, Saxenda

Novo Nordisk launches weight-loss drug, Saxenda

Danish drug maker Novo Nordisk has launched its own weight-loss drug, Saxenda — and at upwards of $1,000 a month, it isn’t going to be cheap. The drug — an injectable called liraglutide previously used for diabetes — is for chronic weight management in adults with a body mass index (BMI) of more than 30

Read more